AnaptysBio
ANAB
ANAB
127 hedge funds and large institutions have $1.7B invested in AnaptysBio in 2019 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 61 increasing their positions, 24 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
20% less capital invested
Capital invested by funds: $2.13B → $1.7B (-$424M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less call options, than puts
Call options by funds: $5.51M | Put options by funds: $11.1M
Holders
127
Holding in Top 10
1
Calls
$5.51M
Puts
$11.1M
Top Buyers
| 1 | +$61.7M | |
| 2 | +$29M | |
| 3 | +$27.4M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$19.2M |
| 5 |
BlackRock
New York
|
+$13.7M |
Top Sellers
| 1 | -$14M | |
| 2 | -$12.4M | |
| 3 | -$11.4M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$8.4M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$7.16M |